Treatment success rate for patients treated for MDR-TB in Eastern Mediterranean (WHO region)

Eastern Mediterranean (WHO region): Treatment success rate for patients treated for MDR-TB was 75.0% in 2022. ▲ Rising

Latest (2022)
75.0%
Change on year
up 1.4%
Rank
4th
of 11 groups
All-time high
75.0%
in 2022
All-time low
29.0%
in 2004
Years of data
20
2002–2022

Treatment success rate for patients treated for MDR-TB in Eastern Mediterranean (WHO region), 2002–2022

0204060802002201220222002: 572003: 562004: 292006: 382007: 572008: 562009: 442010: 562011: 652012: 652013: 682014: 652015: 622016: 652017: 642018: 682019: 722020: 732021: 742022: 75

Source: World Health Organization, Global Health Observatory.

Analysis

In 2022, treatment success rate for patients treated for mdr-tb in Eastern Mediterranean (WHO region) stood at 75.0%. That is the highest value across all 20 years on record.

Compared with earlier readings it is up 1.4% on the previous year and up 15.4% over ten years.

Over the whole period, treatment success rate for patients treated for mdr-tb in Eastern Mediterranean (WHO region) peaked at 75.0% in 2022 and was at its lowest, 29.0%, in 2004.

The long-run direction has been consistently rising across the 20 years of available data.

Treatment success rate for patients treated for MDR-TB in Eastern Mediterranean (WHO region), year by year

Annual values for Treatment success rate for patients treated for MDR-TB (%) in Eastern Mediterranean (WHO region), 2002 to 2022.
Year Value Change
2002 57.0%
2003 56.0% -1.8%
2004 29.0% -48.2%
2006 38.0% +31.0%
2007 57.0% +50.0%
2008 56.0% -1.8%
2009 44.0% -21.4%
2010 56.0% +27.3%
2011 65.0% +16.1%
2012 65.0% +0.0%
2013 68.0% +4.6%
2014 65.0% -4.4%
2015 62.0% -4.6%
2016 65.0% +4.8%
2017 64.0% -1.5%
2018 68.0% +6.2%
2019 72.0% +5.9%
2020 73.0% +1.4%
2021 74.0% +1.4%
2022 75.0% +1.4%

Biggest year-on-year movements

Years where Treatment success rate for patients treated for MDR-TB in Eastern Mediterranean (WHO region) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2004 -48.2% 56.0% 29.0%
2007 +50.0% 38.0% 57.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 48.1% 29.0% 57.0% 7
2010s 65.0% 56.0% 72.0% 10
2020s 74.0% 73.0% 75.0% 3

Countries ranked near Eastern Mediterranean (WHO region)

  1. 1 New Zealand 100.0% compare
  2. 1 Sao Tome and Principe 100.0% compare
  3. 1 Jordan 100.0% compare
  4. 1 Serbia 100.0% compare
  5. 1 Kuwait 100.0% compare
  6. 1 Belize 100.0% compare
  7. 1 Macau, China 100.0% compare
  8. 1 Mauritius 100.0% compare
  9. 1 Montenegro 100.0% compare
  10. 1 Bahamas 100.0% compare
  11. 1 Kiribati 100.0% compare
  12. 1 Cape Verde 100.0% compare
  13. 1 Puerto Rico 100.0% compare
  14. 1 Costa Rica 100.0% compare
  15. 1 Micronesia, Federated States of 100.0% compare
  16. 1 United Arab Emirates 100.0% compare

See the full ranking of 175 places →

More health data for Eastern Mediterranean (WHO region)

All data for Eastern Mediterranean (WHO region) →

Frequently asked questions

What is treatment success rate for patients treated for mdr-tb in Eastern Mediterranean (WHO region)?
Treatment success rate for patients treated for mdr-tb in Eastern Mediterranean (WHO region) was 75.0% in 2022, according to World Health Organization, Global Health Observatory.
What is the highest treatment success rate for patients treated for mdr-tb recorded in Eastern Mediterranean (WHO region)?
The highest recorded value was 75.0% in 2022.
What is the lowest treatment success rate for patients treated for mdr-tb recorded in Eastern Mediterranean (WHO region)?
The lowest recorded value was 29.0% in 2004.
How does Eastern Mediterranean (WHO region) rank for treatment success rate for patients treated for mdr-tb?
Eastern Mediterranean (WHO region) ranks 4th out of 11 groups with data for 2022.
Is treatment success rate for patients treated for mdr-tb rising or falling in Eastern Mediterranean (WHO region)?
Over the last ten years it is up 15.4%. The long-run trend across the full record is rising.
Where does this Eastern Mediterranean (WHO region) data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Treatment success rate for patients treated for MDR-TB in Eastern Mediterranean (WHO region). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 13 September 2026, from https://health.statizoid.com/stat/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/eastern-mediterranean-who-region/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/eastern-mediterranean-who-region/">Treatment success rate for patients treated for MDR-TB in Eastern Mediterranean (WHO region)</a> — Statizoid

About this data

Indicator
Treatment success rate for patients treated for MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
175 places, 2,495 data points, 1999–2022
Last refreshed